Eli Lilly and Co (WAR:LILY) E10: zł38.12 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:LILY Eli Lilly and Co WAR:LILY
96 GF Score
Price zł4,640.00
GF Value zł6,179.44
! 3 Warning Signs
View Full Analysis

What is Eli Lilly and Co E10?

Eli Lilly and Co WAR:LILY 96 E10 is zł38.12 as of Jun. 2026. GuruFocus rates WAR:LILY with a GF Score™ of 96/100 and a GF Value™ of zł6,179.44. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Jun. 2026 was zł29.494. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is zł38.12 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Eli Lilly and Co's average E10 Growth Rate was 42.00% per year. During the past 3 years, the average E10 Growth Rate was 19.10% per year. During the past 5 years, the average E10 Growth Rate was 14.30% per year. During the past 10 years, the average E10 Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Eli Lilly and Co was 19.10% per year. The lowest was -2.70% per year. And the median was 5.90% per year.

As of today (2026-09-06), Eli Lilly and Co's current stock price is zł4640.00. Eli Lilly and Co's E10 for the quarter that ended in Jun. 2026 was zł38.12. Eli Lilly and Co's Shiller PE Ratio of today is 121.72.

During the past 13 years, the highest Shiller PE Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 55.85.


Eli Lilly and Co  (WAR:LILY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=4640.00/38.12
=121.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 55.85.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Eli Lilly and Co E10 Related Terms


Eli Lilly and Co E10 Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co E10 Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eli Lilly and Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 36.09 38.12

WAR:LILY vs JNJ, ABBV, MRK: E10 Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.


WAR:LILY
96GF Score
Eli Lilly and Co WAR:LILY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=29.494/333.9520*333.9520
=29.494

Current CPI (Jun. 2026) = 333.9520.

Eli Lilly and Co Quarterly Data

per share eps CPI Adj_EPS
201609 2.712 241.428 3.751
201612 2.604 241.432 3.602
201703 -0.371 243.801 -0.508
201706 3.529 244.955 4.811
201709 1.969 246.819 2.664
201712 -5.869 246.524 -7.950
201803 4.309 249.554 5.766
201806 -0.929 251.989 -1.231
201809 4.160 252.439 5.503
201812 3.954 251.233 5.256
201903 16.010 254.202 21.033
201906 5.349 256.143 6.974
201909 5.089 256.759 6.619
201912 5.802 256.974 7.540
202003 5.943 258.115 7.689
202006 5.758 257.797 7.459
202009 4.940 260.280 6.338
202012 8.220 260.474 10.539
202103 5.535 264.877 6.978
202106 5.683 271.696 6.985
202109 4.532 274.310 5.517
202112 6.723 278.802 8.053
202203 7.801 287.504 9.061
202206 3.900 296.311 4.395
202209 5.980 296.808 6.728
202212 7.575 296.797 8.523
202303 5.535 301.836 6.124
202306 7.243 305.109 7.928
202309 -0.223 307.789 -0.242
202312 8.989 306.746 9.786
202403 9.212 312.332 9.850
202406 12.184 314.175 12.951
202409 3.975 315.301 4.210
202412 18.127 315.605 19.181
202503 11.367 319.799 11.870
202506 23.365 322.561 24.190
202509 23.067 324.800 23.717
202512 27.451 324.054 28.289
202603 30.682 330.213 31.029
202606 29.494 333.952 29.494

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of zł38.12 mean?
Eli Lilly and Co (WAR:LILY) has a E10 of zł38.12 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's E10 too high?
Eli Lilly and Co's current E10 is zł38.12. Overall, Eli Lilly and Co has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's E10 compare to JNJ and ABBV?
Eli Lilly and Co's E10 of zł38.12 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors. Eli Lilly and Co's current E10 is zł38.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Eli Lilly and Co (WAR:LILY) has a current E10 of zł38.12. The stock's GF Value™ is zł6,179.44, compared to a current price of zł4,640.00 — trading 24.9% below its estimated fair value. The current E10 is zł38.12. Eli Lilly and Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Eli Lilly and Co (WAR:LILY), the current E10 is zł38.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (WAR:LILY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of zł4,640.00 is trading 24.9% below its estimated GF Value™ of zł6,179.44.

Key valuation signals for WAR:LILY:

  • E10: zł38.12
  • GF Value™: zł6,179.44 vs. price of zł4,640.00 (24.9% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the WAR:LILY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
96GF Score

Get the complete analysis for WAR:LILY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł4,640.00
Price
zł6,179.44
GF Value